46 related articles for article (PubMed ID: 30654366)
1. Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins.
Sala A; Ardizzoni A; Ciociola T; Magliani W; Conti S; Blasi E; Cermelli C
Intervirology; 2018; 61(4):166-173. PubMed ID: 30654366
[TBL] [Abstract][Full Text] [Related]
2. Antiviral activity of a Bacillus sp. P34 peptide against pathogenic viruses of domestic animals.
Scopel e Silva D; de Castro CC; da Silva e Silva F; Sant'anna V; Vargas GD; de Lima M; Fischer G; Brandelli A; da Motta Ade S; Hübner Sde O
Braz J Microbiol; 2014; 45(3):1089-94. PubMed ID: 25477947
[TBL] [Abstract][Full Text] [Related]
3. Augmented antiviral activity of chlorhexidine gluconate on herpes simplex virus type 1, H1N1 influenza A virus, and adenovirus in combination with salicylic acid.
Jamshidinia N; Saadatpour F; Arefian E; Mohammadipanah F
Arch Virol; 2023 Nov; 168(12):302. PubMed ID: 38036721
[TBL] [Abstract][Full Text] [Related]
4. Melittin: a venom-derived peptide with promising anti-viral properties.
Memariani H; Memariani M; Moravvej H; Shahidi-Dadras M
Eur J Clin Microbiol Infect Dis; 2020 Jan; 39(1):5-17. PubMed ID: 31422545
[TBL] [Abstract][Full Text] [Related]
5. Antiviral Peptides Derived from Plants: Their Designs and Functions.
Feyzyab H; Fathi N; Bolhassani A
Protein Pept Lett; 2023; 30(12):975-985. PubMed ID: 38013436
[TBL] [Abstract][Full Text] [Related]
6. Rationally Designed ACE2-Derived Peptides Inhibit SARS-CoV-2.
Larue RC; Xing E; Kenney AD; Zhang Y; Tuazon JA; Li J; Yount JS; Li PK; Sharma A
Bioconjug Chem; 2021 Jan; 32(1):215-223. PubMed ID: 33356169
[TBL] [Abstract][Full Text] [Related]
7. Antiviral Peptides: Identification and Validation.
Agarwal G; Gabrani R
Int J Pept Res Ther; 2021; 27(1):149-168. PubMed ID: 32427225
[TBL] [Abstract][Full Text] [Related]
8. Computational Design of ACE2-Based Peptide Inhibitors of SARS-CoV-2.
Han Y; Král P
ACS Nano; 2020 Apr; 14(4):5143-5147. PubMed ID: 32286790
[TBL] [Abstract][Full Text] [Related]
9. Antiviral peptides as promising therapeutic drugs.
Vilas Boas LCP; Campos ML; Berlanda RLA; de Carvalho Neves N; Franco OL
Cell Mol Life Sci; 2019 Sep; 76(18):3525-3542. PubMed ID: 31101936
[TBL] [Abstract][Full Text] [Related]
10. The Synthetic Peptide GA-Hecate and Its Analogs Inhibit Multiple Steps of the Chikungunya Virus Infection Cycle In Vitro.
Ayusso GM; da Silva Sanches PR; Carvalho T; Santos IA; Martins DOS; Lima MLD; da Conceição PJP; Bittar C; Merits A; Cilli EM; Jardim ACG; Rahal P; Calmon MF
Pharmaceuticals (Basel); 2023 Sep; 16(10):. PubMed ID: 37895860
[TBL] [Abstract][Full Text] [Related]
11. Computer-Aided Screening for Potential Coronavirus 3-Chymotrypsin-like Protease (3CLpro) Inhibitory Peptides from Putative Hemp Seed Trypsinized Peptidome.
Prasertsuk K; Prongfa K; Suttiwanich P; Harnkit N; Sangkhawasi M; Promta P; Chumnanpuen P
Molecules; 2022 Dec; 28(1):. PubMed ID: 36615263
[TBL] [Abstract][Full Text] [Related]
12. Recent Patents and FDA-Approved Drugs Based on Antiviral Peptides and Other Peptide-Related Antivirals.
Mousavi Maleki MS; Sardari S; Ghandehari Alavijeh A; Madanchi H
Int J Pept Res Ther; 2023; 29(1):5. PubMed ID: 36466430
[TBL] [Abstract][Full Text] [Related]
13. Virtual Screening for SARS-CoV-2 Main Protease Inhibitory Peptides from the Putative Hydrolyzed Peptidome of Rice Bran.
Harnkit N; Khongsonthi T; Masuwan N; Prasartkul P; Noikaew T; Chumnanpuen P
Antibiotics (Basel); 2022 Sep; 11(10):. PubMed ID: 36289976
[TBL] [Abstract][Full Text] [Related]
14. Leveraging the therapeutic, biological, and self-assembling potential of peptides for the treatment of viral infections.
Monroe MK; Wang H; Anderson CF; Jia H; Flexner C; Cui H
J Control Release; 2022 Aug; 348():1028-1049. PubMed ID: 35752254
[TBL] [Abstract][Full Text] [Related]
15. Peptide-Based Vaccines and Therapeutics for COVID-19.
Bagwe PV; Bagwe PV; Ponugoti SS; Joshi SV
Int J Pept Res Ther; 2022; 28(3):94. PubMed ID: 35463185
[TBL] [Abstract][Full Text] [Related]
16. 1,2,3-Triazoles as Biomimetics in Peptide Science.
Agouram N; El Hadrami EM; Bentama A
Molecules; 2021 May; 26(10):. PubMed ID: 34069302
[TBL] [Abstract][Full Text] [Related]
17. Compelling Evidence for the Activity of Antiviral Peptides against SARS-CoV-2.
Tonk M; Růžek D; Vilcinskas A
Viruses; 2021 May; 13(5):. PubMed ID: 34069206
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial Activity of Cyclic-Monomeric and Dimeric Derivatives of the Snail-Derived Peptide Cm-p5 against Viral and Multidrug-Resistant Bacterial Strains.
González-García M; Morales-Vicente F; Pico ED; Garay H; Rivera DG; Grieshober M; Raluca Olari L; Groß R; Conzelmann C; Krüger F; Zech F; Prelli Bozzo C; Müller JA; Zelikin A; Raber H; Kubiczek D; Rosenau F; Münch J; Stenger S; Spellerberg B; Franco OL; Rodriguez Alfonso AA; Ständker L; Otero-Gonzalez AJ
Biomolecules; 2021 May; 11(5):. PubMed ID: 34067685
[TBL] [Abstract][Full Text] [Related]
19. Antiviral peptides against Coronaviridae family: A review.
Heydari H; Golmohammadi R; Mirnejad R; Tebyanian H; Fasihi-Ramandi M; Moosazadeh Moghaddam M
Peptides; 2021 May; 139():170526. PubMed ID: 33676968
[TBL] [Abstract][Full Text] [Related]
20. Anti-Infective Antibody-Derived Peptides Active against Endogenous and Exogenous Fungi.
Ciociola T; Giovati L; Conti S; Magliani W
Microorganisms; 2021 Jan; 9(1):. PubMed ID: 33435157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
